# Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting

> **NCT01159639** · PHASE4 · COMPLETED · sponsor: **University of Zagreb** · enrollment: 200 (actual)

## Conditions studied

- Coronary Artery Disease
- Aspirin Resistance

## Interventions

- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01159639
- **Lead sponsor:** University of Zagreb
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2013-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01159639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01159639, "Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT01159639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*